INZY
Companies
NASDAQ
Inozyme Pharma, Inc.
Health Care
$3.99
+$1.21 (+43.86%)
Price Chart
Overview
About INZY
we are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. our area of expertise is in disorders of paradoxical mineralization and our lead drug is an enzyme replacement therapy in pre-clinical development.
Market Cap
$286.4M
Volume
1.7M
Avg. Volume
2.0M
P/E Ratio
-0.5651852
Dividend Yield
0.00%
Employees
59.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.67
Low Correlation
Volatility
High (0.79)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, INZY shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$286.4M
Volume1.7M
P/E Ratio-0.57
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 10, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025